Stay updated on Adagrasib + BI 1701963 in Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.

Latest updates to the Adagrasib + BI 1701963 in Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.14.4 to v2.15.0.SummaryDifference0.9%
- Check22 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date reference of 2025-03-25 while adding a new date of 2024-12-16.SummaryDifference1%
- Check29 days agoNo Change Detected
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check80 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check87 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Adagrasib + BI 1701963 in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.